Skip to main content
[Preprint]. 2023 May 22:2023.05.22.541727. [Version 1] doi: 10.1101/2023.05.22.541727

Figure 5:

Figure 5:

Compound 2 and analogues disrupt the MSN–CD44 PPI. (A) Structures of compound 2 and analogues, with associated solubility data (PBS, 1% DMSO), and activity in both the MSN–CD44 TR-FRET assay and an unrelated PPI (SYK-FCER1G) TR-FRET assay. Solubility was measured by nephelometry. (B) Dose response of compounds in GST pull down assay. Cell lysates were obtained from cells transfected with full length constructs of GST-tagged MSN and Flag-tagged CD44, and were incubated with the compounds. Immunoblotting was performed to detect GST and Flag, and a representative immunoblot from two experiments is shown. (C) Thermal shift assay, showing representative melting temperature (Tm) curves of MSN with compounds. The average change in Tm (av. ΔTm), compared to DMSO alone, was determined from two experiments (2a: 1.3 °C at 50 μM; 2b: 1.2 °C at 50 μM).